Search results:

Search results from www.aesgp.eu

Ingredient ATC Level 1 ATC Level 2 Year Of Switch Country Status Additional Information
Tolnaftate D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC General Sale when for external use only.
Penciclovir (topical) D Dermatologicals. Dermatologicals D06. Antibiotics and chemotherapeutics for dermatological use 2006 UK OTC In 2014 switched from Pharmacy only to General sale status. For external use for the treatment of herpes simplex virus infections of the lips and face (herpes labialis) in adults and children aged 12 years or over. Maximum strength 1%, maximum pack size 2g.
Sulconazole nitrate (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Pharmacy only status. External use (except vaginal use). However there is currently no marketed OTC product.
Tioconazole D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 1994 UK OTC Pharmacy only for external use, maximum strength 2%. Pharmacy supply when for the treatment of vaginal candidiasis. However there is currently no marketed OTC product.
Docosanol (topical) D Dermatologicals. Dermatologicals D06. Antibiotics and chemotherapeutics for dermatological use — UK OTC Switched from pharmacy-only to General sale status in 2017. For external use only, for the treatment of early stages (prodrome or erythema phase) of recurrent labial herpes simplex infection (cold sores) in immunocompetent patients aged 12 years and over. Maximum strength 10%, maximum pack size 2g.
Aluminium hydroxide A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders — UK OTC General sale.
Isoconazole (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Isoconazole nitrate. External use but in the case of vaginal use, only external use for the treatment of vaginal candidiasis. Pharmacy only status.
Selenium sulphide D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Pharmacy only status. Shampoo for the management of simple dandruff and seborrhoeic dermatitis of the scalp in adults and children over 5 years.
Miconazole & Hydrocortisone (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Pharmacy only for the treatment of athlete's foot and candidal intertrigo. Maximum strength hydrocortisone 1%, maximum pack/container size 15g.
Terbinafine D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 2000 UK OTC In 2001, the 1% spray formulation was allowed for sale without a prescription for the treatment of tinea pedis, tinea cruris, and tinea corporis. Maximum strength 1%, maximum pack size 30ml. In 2001, the 1% gel formulation was allowed for the same indications in a maximum pack size of 30g. As from 2004, a cream preparation may be supplied as a General Sale medicine for the treatment of tinea pedis and tinea cruris (max pack size 15g). As from November 2009, a 1% cutaneous solution, to be administered as a single application (max pack size 4g), may be supplied on general sale for the treatment of tinea pedis in persons aged 18 years and older.
Aciclovir (topical) D Dermatologicals. Dermatologicals D06. Antibiotics and chemotherapeutics for dermatological use 1993 UK OTC Maximum strength 5%. For treatment of herpes simplex virus infections of the lips and face (herpes labialis). Maximum pack/container size 2g. From 2004, 5% cream may be supplied on general sale for the treatment of cold sores.
Rabeprazole A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 2012 UK OTC March 2012: Rabeprazole sodium 10mg gastro-resistant tablets may be supplied without a prescription (Pharmacy only status) for the short-term symptomatic treatment of gastro-oesophageal reflux-like symptoms (e.g. heartburn) in adults aged 18 and over, for a maximum period of 4 weeks, with a maximum dose of 10mg and a maximum daily dose of 10mg, and in a maximum pack size of 14 tablets (140mg rabeprazole).
Ranitidine A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 1994 UK OTC Pharmacy only for the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity or for the prevention of these symptoms when associated with consuming food and drink. Maximum dose 75mg, maximum daily dose 300mg, for a maximum period of 14 days. General sale restricted to maximum pack size of 12 tablets for the symptomatic relief of heartburn, dyspepsia, indigestion, and hyperacidity with a maximum strength of 75mg and maximum daily dose of 150mg.
Cimetidine A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 1994 UK OTC For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity and for the prophylaxis of meal-induced heartburn, maximum dose 200mg, maximum daily dose 800mg, maximum treatment period 14 days. For the prophylactic management of nocturnal heartburn, maximum dose 100mg, to be taken as a single dose at night, maximum treatment period 14 days. Pharmacy-only.
Famotidine A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 1994 UK OTC Pharmacy only where for the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity, and prevention of these symptoms when associated with food and drink, including nocturnal symptoms. Maximum dose 10mg and maximum daily dose 20mg. For a maximum period of 14 days. General sale since 2000 for the short-term symptomatic relief of heartburn, indigestion, acid indigestion and hyperacidity, maximum dose 10mg, maximum daily dose 20mg and maximum 12 tablets per pack.
Dimeticone A Alimentary tract and metabolism. Alimentary tract and metabolism A03. Drugs for functional gastrointestinal disorders — UK OTC Activated Dimeticone is available with General Sale status for the relief of wind, trapped gas and bloating. Liquid formulations are available for babies and children and solid formulations for adults and children. In addition, Dimeticone since 2009 may be supplied on general sale for the eradication of headlice infestations in adults and children aged 6 months and over. Maximum strength 4%, maximum pack size 100ml.
Fluoride (sodium) A Alimentary tract and metabolism. Alimentary tract and metabolism A01. Stomatological preparations — UK OTC GSL in 2001 with a maximum strength of 0.05% for daily use mouth rinses and with a maximum strength of 0.2% for mouthwashes for other than daily use. Dentifrices with a maximum strength of 0.33% are also GSL. Preparations for the use in prevention of dental caries in the form of tablets or drops 2.2mg maximum daily dose are pharmacy only.
Calcium carbonate A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders — UK OTC General sale.
Hexetidine A Alimentary tract and metabolism. Alimentary tract and metabolism A01. Stomatological preparations — UK OTC GSL if maximum strength 0.1% (external use only).
Nizatidine A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 1996 UK OTC Pharmacy only for the prevention and treatment of the symptoms of food-related heartburn, and meal-induced indigestion. For use in adults and children over 16. Maximum dose 75mg, maximum daily dose 150mg. For a maximum period of 14 days.
Miconazole (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 1997 UK OTC Miconazole nitrate. Maximum strength 2% for cream or powder (in case of spray powders 2% w/w excluding any propellants). General Sale for external use for the treatment of tinea pedis only. Pharmacy only status for fungal and associated bacterial infections of skin including nappy rash.
Ketoconazole (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 1995 UK OTC Pharmacy only supply as shampoo for the prevention and treatment of dandruff and seborrhoeic dermatitis of the scalp. Maximum frequency of application: once every 3 days, maximum strength: 2% w/v, maximum pack size: 120ml of product, containing not more than 2400mg of ketoconazole. Pharmacy only supply also for the treatment of tinea pedis, tinea cruris and candidal intertrigo. Maximum strength: 2% w/w. General Sale (GSL) (in 2002) supply where a shampoo, for the prevention and treatment of dandruff and where maximum strength 2% w/v, maximum pack size 100ml of product. GSL also as a cream, for the treatment of tinea pedis and tinea cruris, with maximum strength 2% w/w and maximum pack size 30g.
Carbenoxolone A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 1992 UK OTC (Sodium). Pharmacy only if pellet maximum dose 5mg, maximum daily dose 25mg, gel maximum strength 2%, or granules for mouthwash in adults and children over 12 years, maximum dose 20mg, maximum daily dose 80mg and maximum strength 1% and container or package containing maximum 560mg carbenoxolone sodium. No product currently marketed.
Nystatin D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 1999 UK OTC Pharmacy only when for external use in combination with Hydrocortisone of maximum strength 0.5 per cent for intertrigo. For use in adults and children not less than 10 years. Maximum strength 3%, maximum pack size 15g.
Bisacodyl A Alimentary tract and metabolism. Alimentary tract and metabolism A06. Laxatives — UK OTC Bisacodyl is pharmacy only unless the following conditions are met: maximum dose 10mg for general sale to adults and children over 10 years (maximum pack size 60 tablets, maximum strength 5mg).
Lactitol A Alimentary tract and metabolism. Alimentary tract and metabolism A06. Laxatives — UK OTC No product currently marketed. Pharmacy only.
Lactulose A Alimentary tract and metabolism. Alimentary tract and metabolism A06. Laxatives — UK OTC Pharmacy only status.
Macrogol (Polyethylene glycol 3350) A Alimentary tract and metabolism. Alimentary tract and metabolism A06. Laxatives — UK OTC Pharmacy only status but not actively marketed to the public. Almost always prescribed by a health professional.
Picosulfate (sodium) A Alimentary tract and metabolism. Alimentary tract and metabolism A06. Laxatives 1997 UK OTC General sale if for adults and children over 10 years. Maximum strength 0.1%, maximum dose 15mg, maximum daily dose 15mg, maximum pack size 60ml. In 2004, the conditions for GSL supply were extended to include liquid-filled capsules with a maximum strength of 2.5mg and maximum pack size of 24 capsules.
Loperamide A Alimentary tract and metabolism. Alimentary tract and metabolism A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents 1997 UK OTC General sale for the symptomatic treatment of acute diarrhoea in adults and children over 12 years. For the symptomatic treatment of acute episodes of diarrhoea associated with irritable bowel syndrome in adults aged 18 years and over following initial diagnosis by a doctor. Maximum strength 2mg, maximum dose 4mg, maximum daily dose 12mg, maximum pack size 6 caps or tabs. Pharmacy only for treatment of acute diarrhoea.
Dicyclomine (Dicycloverine) A Alimentary tract and metabolism. Alimentary tract and metabolism A03. Drugs for functional gastrointestinal disorders — UK OTC Pharmacy only. Maximum dose 10mg, maximum daily dose 60mg.
Orlistat A Alimentary tract and metabolism. Alimentary tract and metabolism A08. Antiobesity preparations 2009 UK OTC Orlistat 60mg was switched to non-prescription status under the centralised procedure in the entire European Union through a European Commission Decision dated 12 January 2009. The switch was also implemented in Croatia, Norway and Switzerland. Available as a pharmacy only medicine for weight loss in adults who are overweight (body mass index, BMI, ≥28 kg/m2) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.
Vitamin A (Retinol) A Alimentary tract and metabolism. Alimentary tract and metabolism A11. Vitamins — UK OTC General sale. Maximum daily dose 7500iu (2250 micrograms Retinol equivalent).
Selenium A Alimentary tract and metabolism. Alimentary tract and metabolism A12. Mineral supplements — UK OTC Available in combination in multivitamin and mineral products in both pharmacy only products and food supplements. Selenium sulphide classified as pharmacy only.
Tranexamic acid B Blood and blood forming organs. Blood and blood forming organs B02. Antihemorrhagics 2010 UK OTC Tranexamic acid 500mg tablets were switched to non-prescription (pharmacy-only) status in 2010 for the reduction of heavy menstrual bleeding (menorrhagia) over several cycles in women aged 18 to 45 years with regular, 21-35 days cycles with no more than 3 days individual variability in cycle duration. Maximum dose 1g, maximum daily dose 4g, maximum treatment period 4 days, maximum pack size 18 tablets.
Adenosine C Cardiovascular system. Cardiovascular system C01. Cardiac therapy 2003 UK OTC For oral administration at a maximum daily dose of 750 micrograms. Product should not be taken for longer than 12 weeks without medical advice. Not for children under 14 years of age. Pharmacy only status.
Nitro-glycerine C Cardiovascular system. Cardiovascular system C01. Cardiac therapy — UK OTC Pharmacy only status.
Hyoscine butylbromide A Alimentary tract and metabolism. Alimentary tract and metabolism A03. Drugs for functional gastrointestinal disorders 1991 UK OTC Pharmacy-only status: 1/ By inhaler - 2/ Otherwise than by inhaler: maximum dose 20mg, maximum daily dose 80mg, maximum pack size 240mg. For the symptomatic relief of irritable bowel syndrome. General Sale status (from 2004): Tablets for the relief of gastrointestinal tract spasm associated with medically confirmed irritable bowel syndrome (IBS) in adults and children aged 12 years and over. Maximum strength 10mg, maximum dose 20mg, maximum daily dose 80mg, maximum pack size 40 tablets.
Mebeverine A Alimentary tract and metabolism. Alimentary tract and metabolism A03. Drugs for functional gastrointestinal disorders 1997 UK OTC Pharmacy only status. For the symptomatic treatment of irritable bowel syndrome, maximum dose 135mg, maximum daily dose 405mg. For other uses: maximum dose 100mg, maximum daily dose 300mg.
Simvastatin C Cardiovascular system. Cardiovascular system C10. Lipid modifying agents 2004 UK OTC Simvastatin 10mg switched to pharmacy status for use in conjunction with necessary lifestyle changes to reduce the risk of a first major coronary event in people likely to be at a moderate risk (approximately 10-15% 10-year risk of a first major event) of coronary heart disease (CHD)). Maximum strength 10mg, maximum daily dose 10mg, maximum pack size 28 tablets. Not currently marketed under OTC.
Amorolfine (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 2006 UK OTC Amorolfine hydrochloride nail lacquer was switched to pharmacy (P) status on 15 September 2006 for the treatment of mild cases of distal and lateral subungual onychomycoses caused by dermatophytes, yeasts and moulds limited up to 2 nails. Dosage: a once-weekly administration. Maximum strength: 5% amorolfine (as the base). Maximum pack size: 3ml (equivalent to approximately 3 months' treatment).
Bifonazole D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Pharmacy only status unless a cream for the treatment of athlete's foot when it will be General Sale (GSL). Maximum strength 1%, maximum pack size 30g of product for GSL products.
Propantheline A Alimentary tract and metabolism. Alimentary tract and metabolism A03. Drugs for functional gastrointestinal disorders — UK OTC (Bromide). Pharmacy only status if maximum dose 15mg, maximum daily dose 45mg. However there is no marketed OTC product.
Omeprazole A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 2004 UK OTC Pharmacy-only medicine for the relief of reflux-like symptoms such as heartburn in adults aged 18 years and over. Maximum treatment period 2 weeks. Maximum strength 20mg, maximum dose 20mg, maximum daily dose 20mg, maximum pack size 14 tablets. 10mg capsules reclassified to P in 2004. 20mg gastro-resistant capsules reclassified to P in 2013.
Clotrimazole (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use — UK OTC Maximum strength 1%. For external use for prevention of (2001) or as an adjunct to the treatment of tinea pedis. Maximum 500mg in an individual container or package (General sale in 1995).
Dimenhydrinate (diphenhydramine and 8-chlorotheophylline) A Alimentary tract and metabolism. Alimentary tract and metabolism A04. Antiemetics and antinauseants — UK OTC Pharmacy-only status.
Hyoscine (Scopolamine) A Alimentary tract and metabolism. Alimentary tract and metabolism A04. Antiemetics and antinauseants 1992 UK OTC Hyoscine hydrobromide. Pharmacy only status when maximum dose 300 micrograms, maximum daily dose 900 micrograms. External (except ophthalmic) / internal (otherwise than by inhaler) routes. Hyoscine patches became available as a pharmacy-only product in 2004 for the prevention of travel sickness symptoms. For use in adults and children aged 10 years or over. Maximum strength: 1.5mg per patch, maximum pack size: 2 patches. Other preparations for internal use: maximum strength: 0.15%.
Fenticonazole (topical) D Dermatologicals. Dermatologicals D01. Antifungals for dermatological use 2001 UK OTC Pharmacy only status when for external use only for the treatment of vaginal candidiasis.
Pantoprazole A Alimentary tract and metabolism. Alimentary tract and metabolism A02. Drugs for acid related disorders 2009 UK OTC Pantoprazole 20mg was switched to non-prescription status in the entire European Union through a Decision of the European Commission under the centralised procedure dated 12 June 2009. Pantoprazole is available as a pharmacy only medicine, 20mg (one tablet) per day, maximum pack size 14 tablets. For the short-term symptomatic treatment of gastro-oesophageal reflux-like symptoms (e.g. heartburn) in adults aged 18 years and over.
Alclometasone (topical) D Dermatologicals. Dermatologicals D07. Corticosteroids, dermatological preparations 2009 UK OTC Alclometasone dipropionate 0.05% w/w cream is available from pharmacies only for the short-term treatment and control of patches of eczema and dermatitis including atopic eczema and primary irritant and allergic dermatitis in adults and children aged 12 years and older. Maximum pack size 15g.
  • Page 1 of 6
  • 50 of 267 ingredients